A Universal Vaccine Against Any Viral Variant? A New Study Suggests It’s Possible Source Cluster: Singularity Hub Source Node: 1968314Time Stamp: Apr 22, 2024
A Universal Vaccine Against Any Viral Variant? A New Study Suggest It’s Possible Source Cluster: Singularity Hub Source Node: 1967457Time Stamp: Apr 22, 2024
Cell Therapies Now Beat Back Once Untreatable Blood Cancers. Scientists Are Making Them Even Deadlier. Source Cluster: Singularity Hub Source Node: 1966224Time Stamp: Apr 19, 2024
This Company Is Growing Mini Livers Inside People to Fight Liver Disease Source Cluster: Singularity Hub Source Node: 1963533Time Stamp: Apr 11, 2024
Viruses Finally Reveal Their Complex Social Life | Quanta Magazine Source Cluster: Quantamagazine Source Node: 1963353Time Stamp: Apr 11, 2024
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 Source Cluster: JCN Newswire Source Node: 1962795Time Stamp: Apr 10, 2024
A New Treatment Rejuvenates Aging Immune Systems in Elderly Mice Source Cluster: Singularity Hub Source Node: 1960047Time Stamp: Mar 29, 2024
Cell Therapy Takes Aim at Deadly Brain Tumors in Two Clinical Trials Source Cluster: Singularity Hub Source Node: 1958004Time Stamp: Mar 21, 2024
Irresistible: Hooks, habits and why you can’t put down your phone Source Cluster: We Live Security Source Node: 1954028Time Stamp: Mar 5, 2024
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Source Cluster: JCN Newswire Source Node: 1953594Time Stamp: Mar 4, 2024
Singaporeans are Armouring Up Against Viral Infections and Diseases with LAC’s Immunity Arsenal Source Cluster: ACN Newswire Source Node: 1953810Time Stamp: Mar 4, 2024
An Antibiotic You Inhale Can Deliver Medication Deep Into the Lungs Source Cluster: Singularity Hub Source Node: 1947122Time Stamp: Feb 12, 2024
A One-and-Done Injection to Slow Aging? New Study in Mice Opens the Possibility Source Cluster: Singularity Hub Source Node: 1944940Time Stamp: Feb 5, 2024
Aviceda Therapeutics Announces First Patient Dosed in Part 2 of the Phase 2/3 SIGLEC Clinical Trial Assessing AVD-104 for the Treatment of Geographic Atrophy Source Cluster: Fintech News Source Node: 1944220Time Stamp: Feb 3, 2024
FLASH irradiation spares immune cells during proton therapy – Physics World Source Cluster: Physics World Source Node: 1942807Time Stamp: Jan 30, 2024
Macrophage-adhering micropatches enable MRI to detect brain inflammation – Physics World Source Cluster: Physics World Source Node: 1940152Time Stamp: Jan 23, 2024
Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Source Cluster: ACN Newswire Source Node: 1937867Time Stamp: Jan 17, 2024
Former Secretary of State Mike Pompeo Joins Cyabra Board of Directors Source Cluster: Dark reading Source Node: 1936398Time Stamp: Jan 12, 2024
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050 Source Cluster: JCN Newswire Source Node: 1935133Time Stamp: Jan 9, 2024
Medical physics and biotechnology: highlights of 2023 – Physics World Source Cluster: Physics World Source Node: 1930257Time Stamp: Dec 27, 2023